antibiotic therapy
Jump to navigation
Jump to search
Adverse effects
- 25% of patients who receive at least 2 weaks of IV antibiotics develop eosinophilia[6]
- only vancomycin associated with excess risk of dress DRESS[6]
Management
- empiric antibiotic therapy should be tailored to provide the narrowist spectrum antibiotic possible as soon as culture results become available[1][2]
- blood cultures should be drawn prior to initiation of intravenous antibiotic therapy
- all patients on IV antibiotics with intact GI system whose clinical status is improving should be considered for switch to oral therapy[1][2]
- oral antibiotics can be used to treat serious infections[3]
- continued inpatient monitoring of stable patients after transition from IV to oral antibiotics does not improve outcomes[1]
- outpatient parenteral antibiotics may be appropriate for selected patients[1]
More general terms
More specific terms
Additional terms
- antibiotic allergy
- antibiotic prescribing practices; antibiotic overuse; outpatient parenteral antibiotics
- antibiotic prophylaxis
- duration of antibiotic therapy
- failure of antibiotic therapy
References
- ↑ Jump up to: 1.0 1.1 1.2 1.3 1.4 Medical Knowledge Self Assessment Program (MKSAP) 17, 18. American College of Physicians, Philadelphia 2015, 2018.
- ↑ Jump up to: 2.0 2.1 2.2 Masterton RG Antibiotic de-escalation. Crit Care Clin. 2011 Jan;27(1):149-62 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21144991
- ↑ Jump up to: 3.0 3.1 Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am. 2006 Nov;90(6):1197-222. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17116444
- ↑ Chapman AL. Outpatient parenteral antimicrobial therapy. BMJ. 2013 Mar 26;346:f1585. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23532865
- ↑ Seaton RA, Barr DA. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Intern Med. 2013 Oct;24(7):617-23. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23602223
- ↑ Jump up to: 6.0 6.1 6.2 Blumenthal KG et al. Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. J Allergy Clin Immunol 2015 Nov; 136:1288. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25981739
- ↑ Cyriac JM, James E. Switch over from intravenous to oral therapy: A concise overview. J Pharmacol Pharmacother. 2014 Apr;5(2):83-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24799810 Free PMC Article